Literature DB >> 6223044

Insulin resistance in nonobese patients with polycystic ovarian disease.

R J Chang, R M Nakamura, H L Judd, S A Kaplan.   

Abstract

To determine whether insulin resistance occurs in polycystic ovarian disease (PCO) in the absence of obesity and acanthosis nigricans, circulating levels of insulin in response to oral glucose administration were measured in 10 nonobese PCO patients without acanthosis nigricans and in 10 normal women matched for weight and height. Mean serum testosterone (T), androstenedione (A), dehydroepiandrosterone (D), D sulfate, and LH levels were significantly elevated in the PCO patients compared to those in control subjects. In PCO patients, the mean +/- SE basal insulin level (18.7 +/- 2.9 microU/ml) and the sum of the insulin levels in response to glucose (674 +/- 119 microU/ml) were significantly greater than those in the control group (11.0 +/- 0.8 microU/ml and 248 +/- 29 microU/ml, respectively). In all subjects, serum levels of T and A, but not D and D sulfate, were significantly correlated to basal insulin levels and insulin sums. Serum cortisol, GH, and PRL levels were similar in both groups. These results indicate that in PCO, a significant degree of insulin resistance exists, which clearly is not related to obesity. The positive correlation of serum T and A levels to circulating insulin levels in this study suggests that the insulin resistance in PCO may be, in part, a consequence of hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223044     DOI: 10.1210/jcem-57-2-356

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  96 in total

1.  Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.

Authors:  Susan Sam; David A Ehrmann
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

Review 3.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

4.  Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome.

Authors:  Claudia Gagnon; Jean-Patrice Baillargeon
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

5.  Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome.

Authors:  F Orio; E Ferrarini; T Cascella; A Dimida; S Palomba; E Gianetti; A Colao; P Agretti; P Vitti; G Lombardi; A Pinchera; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

6.  Is hyperprolactinemia associated with insulin resistance in non-obese patients with polycystic ovary syndrome?

Authors:  M Bahceci; A Tuzcu; S Bahceci; S Tuzcu
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 7.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

8.  Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

Authors:  Theodore P Ciaraldi; Vanita Aroda; Sunder Mudaliar; R Jeffrey Chang; Robert R Henry
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

9.  Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States).

Authors:  A I Adler; N S Weiss; M L Kamb; J L Lyon
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

10.  Relationship between surrogate estimates and direct measurement of insulin resistance in women with polycystic ovary syndrome.

Authors:  M H Dahan; F Abbasi; G Reaven
Journal:  J Endocrinol Invest       Date:  2019-01-30       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.